Nektar Therapeutics | NKTR - Interest Income


Nektar Therapeutics reported $-0.18 in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
Agios Pharmaceuticals USD 12.41M 959K Dec/2025
ALKERMES USD 8.54M 3.59M Mar/2026
Baxter International USD 11M 1000K Dec/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Biogen USD 37.9M 700K Mar/2026
Cara Therapeutics USD 347K 74K Mar/2025
Dr.Reddys Laboratories INR 796M 116M Dec/2025
Eisai JPY 3.11B 783M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Exelixis USD 16.13M 1.3M Mar/2026
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
Incyte USD 33.69M 2.93M Mar/2026
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Ironwood Pharmaceuticals USD 778K 374K Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.53M 114K Sep/2025
Merck USD 69M 27M Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pfizer USD 115M 51M Mar/2026
Sarepta Therapeutics USD 8.74M 359K Dec/2025
Takeda JPY 87.87B 43.48B Dec/2025
Xencor USD 6.2M 338K Dec/2025